Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gopal, Satish
NCT02835911: Clinical Cohort of Lymphoma Patients in Malawi	Recruiting	N/A	800	RoW		UNC Lineberger Comprehensive Cancer Center, National Institutes of Health (NIH), Fogarty International Center of the National Institute of Health	Lymphoma, Hematologic Malignancies	01/30	01/30
Painschab, Matthew
NCT04585893: Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi	Active, not recruiting	2	15	RoW	Rituximab, Rituxan, Etoposide, Toposar, VP-16	UNC Lineberger Comprehensive Cancer Center, Fogarty International Center of the National Institute of Health	Multicentric Castleman Disease	08/25	06/27
KS-CARE, NCT06480773: Kaposi Sarcoma Chemotherapy and Research	Recruiting	N/A	180	RoW	standard of care chemotherapy	UNC Lineberger Comprehensive Cancer Center, National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI)	Kaposi Sarcoma, HIV	06/27	06/27